| Expression pattern: |
UP |
| Associated gene: |
MED1 |
| Associated microRNA: |
miR-1322 |
| Biological function: |
promotes OTSCC cell proliferation, migration, invasion, tumor growth, and disease progression |
| Molecular mechanism: |
circFNDC3B functions through a ceRNA mechanism by sponging miR-1322 and promoting MED1 expression |
| Biological pathway or process: |
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes) |
| Detected method: |
Q
H
|
| Validation methods: |
Back-Splice Junction PCR / divergent primers PCR; RT-qPCR; FISH / smFISH; Clinical Sample Validation; Luciferase Reporter Assay; RNA Pull-Down; Transfection; Colony Formation Assay; Wound Healing Assay; Transwell Assay; In Vivo Animal Model; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
circFNDC3B may be a potential therapeutic target for OTSCC |
| Description: |
circFNDC3B is up-regulated in OTSCC tissues and cell lines and acts as an oncogenic circRNA. It promotes proliferation, migration, invasion, and xenograft tumor growth through the circFNDC3B/miR-1322/MED1 regulatory axis, suggesting potential therapeutic relevance in OTSCC. |
| Confidence score: |
0.7795 |